Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf

Nature Immunology
Edward A MiaoAlan Aderem

Abstract

Macrophages respond to Salmonella typhimurium infection via Ipaf, a NACHT-leucine-rich repeat family member that activates caspase-1 and secretion of interleukin 1beta. However, the specific microbial salmonella-derived agonist responsible for activating Ipaf is unknown. We show here that cytosolic bacterial flagellin activated caspase-1 through Ipaf but was independent of Toll-like receptor 5, a known flagellin sensor. Stimulation of the Ipaf pathway in macrophages after infection required a functional salmonella pathogenicity island 1 type III secretion system but not the flagellar type III secretion system; furthermore, Ipaf activation could be recapitulated by the introduction of purified flagellin directly into the cytoplasm. These observations raise the possibility that the salmonella pathogenicity island 1 type III secretion system cannot completely exclude 'promiscuous' secretion of flagellin and that the host capitalizes on this 'error' by activating a potent host-defense pathway.

References

Sep 1, 1996·Molecular Microbiology·L M ChenJ E Galán
Nov 26, 1998·The Journal of Biological Chemistry·H HilbiA Zychlinsky
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·D HershA Zychlinsky
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·E A Miao, S I Miller
Dec 6, 2000·Microbiology and Molecular Biology Reviews : MMBR·G S Chilcott, K T Hughes
Jan 3, 2001·Molecular Microbiology·S A LloydH Wolf-Watz
May 26, 2001·Biochemical and Biophysical Research Communications·B J GeddesJ Bertin
Jun 8, 2001·The Journal of Biological Chemistry·J L PoyetE S Alnemri
Jul 27, 2001·Genomics·J S DamianoJ C Reed
Aug 16, 2001·Trends in Biochemical Sciences·C H Weber, C Vincenz
Nov 1, 2001·Annual Review of Cell and Developmental Biology·J E Galán
Apr 6, 2002·Current Opinion in Microbiology·Phillip Aldridge, Kelly T Hughes
Apr 23, 2002·The Journal of Biological Chemistry·Srinivasa M SrinivasulaEmad S Alnemri
Aug 31, 2002·International Immunology·Steven E ApplequistHans-Gustaf Ljunggren
Oct 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jonathan A HartonJenny P-Y Ting
Jan 7, 2003·The Journal of Biological Chemistry·Naohiro InoharaGabriel Nuñez
Jan 16, 2003·The Journal of Biological Chemistry·Stephen E GirardinPhilippe J Sansonetti
May 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Terry K MeansAndrew D Luster
Jun 7, 2003·Science·Stephen E GirardinDana J Philpott
Dec 10, 2003·The Journal of Cell Biology·Lorraine D HernandezJorge E Galán
Feb 6, 2004·Molecular Microbiology·Sang Ho Lee, Jorge E Galán
Jun 11, 2004·Nature·Sanjeev MariathasanVishva M Dixit
Jun 12, 2004·Proceedings of the National Academy of Sciences of the United States of America·Cristina AndreiAnna Rubartelli
Jul 2, 2004·Nature Reviews. Immunology·Shizuo Akira, Kiyoshi Takeda
Dec 15, 2004·International Journal of Medical Microbiology : IJMM·Fons J A M van AstenJaap E van Dijk
Jun 15, 2005·Annual Review of Biochemistry· InoharaGabriel Nuñez
Jun 22, 2005·Trends in Immunology·Fabio Martinon, Jürg Tschopp
Jul 5, 2005·Trends in Microbiology·Thomas A KuferDana J Philpott
Oct 19, 2005·The Journal of Experimental Medicine·Sanjeev MariathasanDenise M Monack
Jan 13, 2006·Nature·Thirumala-Devi KannegantiGabriel Núñez
Jan 13, 2006·Nature·Fabio MartinonJürg Tschopp
Jan 13, 2006·Nature·Sanjeev MariathasanVishva M Dixit

❮ Previous
Next ❯

Citations

Jan 9, 2007·Inflammatory Bowel Diseases·Johan Van LimbergenJack Satsangi
Mar 15, 2008·Inflammatory Bowel Diseases·Frédéric A CarvalhoArlette Darfeuille-Michaud
May 15, 2007·Immunologic Research·Chittur V Srikanth, Bobby J Cherayil
Apr 13, 2013·Current Microbiology·Jaclyn M RehlAmin A Fadl
Jan 22, 2009·Apoptosis : an International Journal on Programmed Cell Death·Christian R McIntireMaya Saleh
Mar 21, 2007·Journal of Clinical Immunology·Ken J Ishii, Shizuo Akira
Nov 21, 2007·Journal of Clinical Immunology·Shee Eun LeeJoon Haeng Rhee
Mar 30, 2010·Journal of Clinical Immunology·Edward A Miao, Sarah E Warren
Apr 8, 2010·Journal of Clinical Immunology·Russell E Vance
May 22, 2010·Journal of Clinical Immunology·Jianghong WuEmad S Alnemri
Feb 11, 2011·Current Infectious Disease Reports·Sarah C Higgins, Kingston H G Mills
Dec 6, 2011·Current Infectious Disease Reports·John SotolongoMasayuki Fukata
Oct 31, 2013·Seminars in Immunology·David PrescottDana J Philpott
Apr 27, 2010·The Proceedings of the Nutrition Society·Carolina Gómez-LlorenteAngel Gil
Nov 6, 2009·Mucosal Immunology·E C LavelleE M Creagh
May 1, 2009·Nature Cell Biology·Igor E Brodsky, Ruslan Medzhitov
Mar 21, 2013·Nature Communications·Zhenyu ZhongLiang Qiao
Oct 24, 2013·Nature Communications·Samarchith P Kurup, Rick L Tarleton
Mar 31, 2010·Nature Immunology·Teresa Fernandes-AlnemriEmad S Alnemri
Mar 21, 2012·Nature Immunology·Luigi FranchiGabriel Núñez
Mar 21, 2012·Nature Immunology·Vijay A K RathinamKatherine A Fitzgerald
May 23, 2006·Nature Immunology·Craig R Roy, Dario S Zamboni
Nov 18, 2006·Nature Immunology·Jörg H FritzStephen E Girardin
Oct 24, 2007·Nature Immunology·Craig R Roy, Edward S Mocarski
May 9, 2012·Nature Medicine·Namiko Hoshi, Ruslan Medzhitov
Jun 2, 2009·Nature Reviews. Drug Discovery·Kaoru GeddesStephen E Girardin
Dec 23, 2006·Nature Reviews. Immunology·Sanjeev Mariathasan, Denise M Monack

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.